News & Analysis
The CAR-T Revolution: Gilead’s Acquisition of Kite Pharma & FDA Approval of Novartis’ Kymriah Signal Tipping Point for Promising Cancer Immunotherapies
The CAR-T Revolution: Gilead’s Acquisition of Kite Pharma & FDA Approval of Novartis’ Kymriah Signal Tipping Point for Promising Cancer Immunotherapies
More
Share
Evolution Infographics
Exploring the History & Viability of Xenotransplantation: CRISPR Off-Target Effects, Porcine Retroviruses, Immune Response & Regulatory Hurdles
Exploring the History & Viability of Xenotransplantation: CRISPR Off-Target Effects, Porcine Retroviruses, Immune Response & Regulatory Hurdles
More
Share
Evolution Infographics
Looking Beyond Genomics: A Holistic Approach to Personalised Medicine
Looking Beyond Genomics: A Holistic Approach to Personalised Medicine
More
Share
Evolution Infographics
Global Therapeutic IPO Market: 27 IPOs Raise Over $2.83B in Q2 2017
Global Therapeutic IPO Market: 27 IPOs Raise Over $2.83B in Q2 2017
More
Share
Evolution Infographics
Thermo Fisher Strengthens Vertical Integration with $7.2B Acquisition of CDMO Patheon
Thermo Fisher Strengthens Vertical Integration with $7.2B Acquisition of CDMO Patheon
More
Share
Evolution Infographics
GE Healthcare Strengthens Cell Therapy Portfolio with Acquisition of Asymptote
GE Healthcare Strengthens Cell Therapy Portfolio with Acquisition of Asymptote
More
Share
Evolution Infographics
The Antibody Quality Conundrum: Market Leaders Adapt to the Five Pillars
The Antibody Quality Conundrum: Market Leaders Adapt to the Five Pillars
More
Share
Evolution Infographics
Pharmaron’s Global Expansion Continues to Build Momentum with Grand Opening of Hoddesdon Facility
Pharmaron’s Global Expansion Continues to Build Momentum with Grand Opening of Hoddesdon Facility
More
Share
News & Analysis
What Assets are J&J Actually Getting with its $30B Acquisition of Actelion?
What Assets are J&J Actually Getting with its $30B Acquisition of Actelion?
More
Share
Evolution Infographics
Lonza’s $5.5B Acquisition of Capsugel Accelerates its “Healthcare Continuum” Strategy
Lonza’s $5.5B Acquisition of Capsugel Accelerates its “Healthcare Continuum” Strategy
More
Share
Evolution Infographics
Drug Development IPOs: Over $4.2B Raised Globally in Q4 2016
Drug Development IPOs: Over $4.2B Raised Globally in Q4 2016
More
Share
News & Analysis
Illumina’s NovaSeq Platform, the $100 Human Genome & Moore’s Law: is it Good Business?
Illumina’s NovaSeq Platform, the $100 Human Genome & Moore’s Law: is it Good Business?

At the JP Morgan Conference on Monday, Illumina took the opportunity showcase its new DNA sequencers, the NovaSeq 5000 and NovaSeq 6000, promising that by the end of the year

More
Share
Evolution Infographics
Autologous CAR-T Cell Therapies: is this the Beginning or the End?
Autologous CAR-T Cell Therapies: is this the Beginning or the End?
More
Share
Evolution Infographics
Medical Time Travel: The History & Business of Cryonics
Medical Time Travel: The History & Business of Cryonics
More
Share
Evolution Infographics
Blood of Their Blood: Young Blood & The Business of Ageing
Blood of Their Blood: Young Blood & The Business of Ageing
More
Share